Stockscreener 앱 받기
47.44
7.67%
3.38
Tectonic Therapeutic Inc 주식(TECX)의 최신 뉴스
Tectonic Therapeutic (NASDAQ:TECX) Stock Price Down 7.1%Should You Sell? - MarketBeat
Analysts Set Tectonic Therapeutic (NASDAQ:TECX) Target Price at $72.25 - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Trading Up 5.5%Time to Buy? - MarketBeat
Brokerages Set Tectonic Therapeutic (NASDAQ:TECX) Target Price at $72.25 - MarketBeat
Fmr LLC Grows Position in Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat
Fmr LLC Has $36.97 Million Holdings in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Verition Fund Management LLC Sells 25,902 Shares of Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat
Walleye Capital LLC Raises Stock Holdings in Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat
Tectonic Therapeutic to Host KOL Event on the Unmet Need in - GlobeNewswire
Tectonic Therapeutic to Host KOL Event on the Unmet Need in Group 2 PH-HFpEF and TX45 as a Potential Treatment on Thursday, December 12, 2024 - Yahoo Finance
Acuta Capital Partners LLC Invests $415,000 in Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat
Wells Fargo Initiates Coverage of Tectonic Therapeutic (TECX) with Overweight Recommendation - MSN
Tectonic Therapeutic To Present on December 3rd, 2024 at the Piper Sandler Healthcare Conference - GlobeNewswire
Tectonic started at outperform by Raymond James, TX45 cited - MSN
Comparing Cellectis (NASDAQ:CLLS) and Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Tectonic started at outperform by Raymond James, TX45 cited (NASDAQ:TECX) - Seeking Alpha
Tectonic Therapeutic (NASDAQ:TECX) Coverage Initiated by Analysts at Raymond James - MarketBeat
Tectonic Therapeutic initiated with an Outperform at Raymond James - TipRanks
Tectonic Therapeutic (NASDAQ:TECX) Hits New 1-Year High Following Analyst Upgrade - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Price Target Raised to $69.00 - Defense World
Tectonic Therapeutic Inc. Faces Challenges with Australian Subsidiary Amid Regulatory and Operational Risks - TipRanks
Tectonic Therapeutic (NASDAQ:TECX) Sets New 52-Week High on Analyst Upgrade - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Shares Gap Up After Analyst Upgrade - Defense World
Tectonic Therapeutic Inc. Reports Q3 2024 Results - Yahoo Finance
BML Capital Management LLC Sells 254,295 Shares of Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says - MarketBeat
Insiders of Tectonic Therapeutic, Inc. (NASDAQ:TECX) were rewarded after last week’s 10% gain - Simply Wall St
Tectonic Therapeutic price target raised to $79 from $55 at Wells Fargo - TipRanks
Tectonic Therapeutic Announces Positive Phase 1a Results in - GlobeNewswire
Tectonic's TX45 Shows Strong Phase 1 Results: 42% Renal Flow Boost, 20-Day Half-Life | TECX Stock News - StockTitan
Brokerages Set Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Price Target at $6.38 - Defense World
Brokerages Set SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Price Target at $68.50 - Defense World
Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Receives $23.83 Average PT from Analysts - Defense World
Vitro Diagnostics (OTCMKTS:VODG) and Tectonic Therapeutic (NASDAQ:TECX) Critical Comparison - Defense World
Tectonic Therapeutic Announces Third Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewswire
Tectonic Therapeutic (NASDAQ:TECX) Reaches New 12-Month HighStill a Buy? - MarketBeat
Mineralys Therapeutics to Participate in Upcoming Investor Conferences - Yahoo Finance
Tectonic Therapeutic (NASDAQ:TECX) Hits New 12-Month High – Still a Buy? - Defense World
Reviewing Tectonic Therapeutic (NASDAQ:TECX) and Mesoblast (NASDAQ:MESO) - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Sets New 1-Year HighTime to Buy? - MarketBeat
X4 Pharmaceuticals (NASDAQ:XFOR) vs. Tectonic Therapeutic (NASDAQ:TECX) Critical Analysis - Defense World
Tectonic Therapeutic Independent Director Acquires 7.0% More Stock - Yahoo Finance
Tectonic Therapeutic (NASDAQ:TECX) Hits New 1-Year High on Insider Buying Activity - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Sets New 52-Week High Following Insider Buying Activity - MarketBeat
Timothy Springer acquires $10.08 million in Tectonic Therapeutic stock By Investing.com - Investing.com Australia
Tectonic Therapeutic (NASDAQ:TECX) Director Acquires $10,077,000.00 in Stock - MarketBeat
Timothy Springer acquires $10.08 million in Tectonic Therapeutic stock - Investing.com India
BioVie Inc. Announces Closing of Registered Direct Offering and Concurrent Private Placement - The Manila Times
Tectonic Therapeutic to Present Phase 1a Data at AHA 2024 - The Bakersfield Californian
2.88%
2.65%
자본화:
|
볼륨(24시간):